Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
According to TipRanks, Slutsky is a 5-star analyst with an average return of 40.4% and a 50.00% success rate. Slutsky covers the Healthcare sector, focusing on stocks such as Spyre Therapeutics, Abivax SA Sponsored ADR, and Olema Pharmaceuticals.
In a report released on June 3, H.C. Wainwright also reiterated a Buy rating on the stock with a $38.00 price target.
Based on Olema Pharmaceuticals’ latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $53.09 million. In comparison, last year the company had a GAAP net loss of $30.39 million
